Nektar Therapeutics Financials

Revenue:

Net income:

Diluted EPS:

All values below without a dollar sign ($) are in millions (1,000,000) except for Earnings Per Share. Sourced from Nektar Therapeutics SEC filings. All data provided as-is without any warranty. Check original SEC filings before making any investment decision.

Income Statement

Quarter Ending	Revenue, Net	Research and Development Expense	Operating Income (Loss)	Nonoperating Income (Expense)	Net Income (Loss) Attributable to Parent	Earnings Per Share, Diluted	Earnings Per Share, Basic	Weighted Average Number of Shares Outstanding, Basic	Weighted Average Number of Shares Outstanding, Diluted
2018 Jun		88	974	2	971	5.33	5.67	171	182
2018 Mar	38	99	-87	-9	-96
2017 Dec	95	81	-24	-10	-34	-0.21	-0.21
2017 Sep	153	66	69	-8	61	0.37	0.39	156	163
2017 Jun	35	60	-51	-9	-60	-0.39	-0.39
2017 Mar	25	61	-54	-9	-64	-0.42	-0.42
2016 Dec	37	50	-32	-10	-42	-0.28	-0.28
2016 Sep	36	52	-33	-10	-43	-0.32	-0.32	137	137
2016 Jun	33	52	-38	-10	-49	-0.36	-0.36
2016 Mar	59	49	-9	-10	-19	-0.14	-0.14	136	136
2015 Dec	39	47	-29	-25	-54	-0.4	-0.4
2015 Sep	60	43	0	-9	-8	-0.06	-0.06	133	133
2015 Jun	23	45	-43	-9	-53	-0.4	-0.4
2015 Mar	109	47	43	-9	34	0.25	0.26	131	136
2014 Dec	20	38	-37	-9	-46	-0.35	-0.35
2014 Sep	133	34	80	-9	71	0.53	0.55	128	132
2014 Jun	29	37	-23	-10	-33	-0.26	-0.26
2014 Mar	20	38	-36	-10	-46	-0.37	-0.37	124	124
2013 Dec	31	48	-36	-10	-48	-0.41	-0.41
2013 Sep	61	44	-7	-10	-17	-0.14	-0.14	116	116
2013 Jun	34	52	-33	-10	-43	-0.37	-0.37
2013 Mar	23	46	-45	-9	-55	-0.48	-0.48
2012 Dec	21	46	-43	-10	-53
2012 Sep	18	34	-33	-10	-44
2012 Jun	24	33	-27	-7	-34
2012 Mar	18	35	-38	-3	-41
2011 Dec	16	33	-34	-2	-37
2011 Sep	27	31	-21	-3	-24
2011 Jun	17	32	-34	-2	-36
2011 Mar	11	30	-34	-2	-36
2010 Dec	45	31	-21	-2	-23
2010 Sep	38	28	-6	-2	-9
2010 Jun	43	26	2	-2	-1
2010 Mar	33	23	-3	-2	-6

Cash Flow

Quarter Ending	Payments to Acquire Property, Plant, and Equipment	Increase (Decrease) in Other Operating Liabilities	Increase (Decrease) in Other Operating Assets	Increase (Decrease) in Inventories	Increase (Decrease) in Deferred Revenue	Increase (Decrease) in Accounts Receivable	Increase (Decrease) in Accounts Payable	Income Tax Expense (Benefit)	Cash and Cash Equivalents, Period Increase (Decrease)
2018 Jun								4
2018 Mar	1	1	-2	0	-4	0	6	0	30
2017 Dec	6	0	7	-2	-38	3	-2	0
2017 Sep								0
2017 Jun								0
2017 Mar	4	-3	-2	2	10	-14	4	0	-36
2016 Dec	5	-6	5	0	-11	-24	1	0
2016 Sep								0
2016 Jun								0
2016 Mar	2	2	-4	0	-7	20	0	0	17
2015 Dec	10	-7	4	-1	-20	17	-3	0
2015 Sep								0
2015 Jun								0
2015 Mar	1	10	-3	0	2	-1	2	0	117
2014 Dec	5	-13	3	0	1	2	0	-1
2014 Sep								0
2014 Jun								0
2014 Mar	5	-1	1	-1	-6	0	-6	0	-7
2013 Dec	4	13	-3	-5	-15	-1	5	2
2013 Sep								0
2013 Jun								0
2013 Mar	0	-4	-4	0	3	-2	1	0	3
2012 Dec	9	4	-2	4	-13	-5	1	0
2012 Sep								0
2012 Jun								0
2012 Mar	2	-1	-4	1	3	6	-1	0	133
2011 Dec	6	1	11	1	-15	3	0	1
2011 Sep								0
2011 Jun								0
2011 Mar	4	-2	1	4	-3	-23	-3	0	5
2010 Dec	27	1	-1	-1	-20	17	3	0
2010 Sep								0
2010 Jun								0
2010 Mar	4	-1	1	2	-27	3	2	0	-29

Assets

Quarter Ending	Cash and Cash Equivalents, at Carrying Value	Available-for-sale Securities	Accounts Receivable, Net, Current	Inventory, Net	Assets, Current	Property, Plant and Equipment, Net	Goodwill	Deferred Revenue, Noncurrent	Deferred Revenue, Current	Assets
2018 Jun	911	1,996	35	12	1,906	45	77			2,313
2018 Mar	35	298	16	11	336	46	77	13	20	497
2017 Dec	5	347	5	11	327	47	77	19	19	509
2017 Sep	38	382	3	14	383	62	77	56	25	582
2017 Jun	16	292	4	11	288	65	77	49	13	476
2017 Mar	23	336	2	13	381	67	77	52	24	528
2016 Dec	60	331	16	11	426	66	77	52	14	569
2016 Sep	63	187	14	11	283	66	77	57	14	425
2016 Jun	56	216	28	10	318	68	77	60	16	463
2016 Mar	73	213	40	11	345	70	77	60	17	492
2015 Dec	56	250	20	11	350	71	77	62	21	502
2015 Sep	19	246	3	10	286	73	77	69	21	449
2015 Jun	21	231	4	10	302	72	77	74	23	457
2015 Mar	129	171	3	13	347	69	77	78	25	499
2014 Dec	12	225	4	13	288	70	77	77	24	442
2014 Sep	32	205	46	12	324	69	77	83	25	477
2014 Jun	31	247	3	14	298	71	77	89	25	478
2014 Mar	32	252	2	13	305	73	77	77	24	487
2013 Dec	39	198	2	13	258	67	77	82	24	435
2013 Sep	65	122	5	15	208	65	77	82	21	383
2013 Jun	41	172	6	20	234	68	77	94	22	413
2013 Mar	29		4	18	267	70	77	98	23	448
2012 Dec	25	252	6	18	315	72	77	97	22	498
2012 Sep	10	319	4	17	347	73	77	102	23	541
2012 Jun	136	341	11	15	468	74	77	108	21	668
2012 Mar	148	350	11	14	421	76	77	111	20	695
2011 Dec	15	400	5	13	277	79	77	108	20	607
2011 Sep	43	415	13	11	298	82	77	113	20	648
2011 Jun	12	470	8	10	389	85	77	118	20	671
2011 Mar	22		2	12	539	88	77	123	20	704
2010 Dec	18	298	25	7	354	90	77	125	21	521
2010 Sep	13
2010 Jun	23
2010 Mar	21